119787 20240319080952.0 doi 10.1111/jch.14489 sideral 128801 ART-2022-128801 eng Pérez-Gimeno, G. Universidad de Zaragoza (orcid)0000-0003-3435-4854 Height-based equations as screening tools for high blood pressure in pediatric practice, the GENOBOX study 2022 Access copy available to the general public Unrestricted Due to the absence of easily applicable cut-off points to determine high blood pressure or hypertension in children, as in the adult population, blood pressure is rarely measured in the pediatrician''s clinical routine. This has led to an underdiagnosis of high blood pressure or hypertension in children. For this reason, the present study evaluate the utility of five equations for the screening of high blood pressure in children: blood pressure to height ratio, modified blood pressure to height ratio, new modified blood pressure to height ratio, new simple formula and height-based equations. The authors evaluated 1599 children between 5 and 18 years. The performance of the five equations was analyzed using the receiver-operating characteristics curves for identifying blood pressure above P90th according to the American Academy of Pediatrics Clinical Practice Guideline 2017. All equations showed an area under the curve above 0.882. The new modified blood pressure to height ratio revealed a high sensitivity whereas the height-based equations showed the best performance, with a positive predictive value above 88.2%. Finally, all equations showed higher positive predictive values in children with overweight or obesity. The height-based equation obtained the highest PPV values above 71.1% in children with normal weight and above 90.2% in children with overweight or obesity. In conclusions, the authors recommend the use of the height-based equations equation because it showed the best positive predictive values to identify children with elevated blood pressure, independently of their sex, pubertal and weight status. © 2022 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. info:eu-repo/grantAgreement/ES/CIBERObn/CB15-00043 info:eu-repo/grantAgreement/ES/ISCIII-FEDER/PI11-01425 info:eu-repo/grantAgreement/ES/ISCIII-FEDER/PI16-01205 info:eu-repo/semantics/openAccess by-nc-nd http://creativecommons.org/licenses/by-nc-nd/3.0/es/ 2.8 2022 PERIPHERAL VASCULAR DISEASE 38 / 68 = 0.559 2022 Q3 T2 0.684 2022 Cardiology and Cardiovascular Medicine 2022 Q2 Internal Medicine 2022 Q2 Endocrinology, Diabetes and Metabolism 2022 Q2 5.2 2022 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Ruperez, A. I. (orcid)0000-0002-3850-8235 Gil-Campos, M. Aguilera, C. M. Anguita, A. Vázquez-Cobela, R. Skapino, E. Moreno, L. A. Universidad de Zaragoza (orcid)0000-0003-0454-653X Leis, R. Bueno-Lozano, G. Universidad de Zaragoza (orcid)0000-0002-0902-387X 1006 255 Universidad de Zaragoza Dpto. Fisiatría y Enfermería Área Enfermería 1011 670 Universidad de Zaragoza Dpto. Microb.Ped.Radio.Sal.Pú. Área Pediatría 24 (2022), 713-722 JOURNAL OF CLINICAL HYPERTENSION JOURNAL OF CLINICAL HYPERTENSION 1524-6175 403628 http://zaguan.unizar.es/record/119787/files/texto_completo.pdf Versión publicada 2357489 http://zaguan.unizar.es/record/119787/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:119787 articulos driver 2024-03-18-13:11:57 ARTICLE